Skip to main content
Aquestive Therapeutics, Inc. logo

Aquestive Therapeutics, Inc. — Investor Relations & Filings

Ticker · AQST ISIN · US03843E1047 US Manufacturing
Open in API
Filings indexed 607 across all filing types
Latest filing 2008-03-27 Regulatory Filings
Country US United States of America
Listing US AQST

About Aquestive Therapeutics, Inc.

https://aquestive.com/

Aquestive Therapeutics is a pharmaceutical company that develops and commercializes medicines using its proprietary PharmFilm® technology. This oral film drug delivery system provides a non-invasive and convenient alternative to conventional therapies, such as injections, by enabling the oral administration of complex molecules. The company's development pipeline is focused on addressing unmet medical needs in central nervous system (CNS) disorders and severe allergic reactions. Key product candidates include Anaphylm™, an epinephrine sublingual film for the emergency treatment of anaphylaxis, and Libervant®, a diazepam buccal film for the management of seizure clusters.

Recent filings

Filing Released Lang Actions
RW
Regulatory Filings Classification · 100% confidence The document is a letter addressed to the SEC requesting withdrawal of a Registration Statement on Form S-1. It explicitly states that the company is not pursuing the initial public offering and requests withdrawal of the filing. There is no financial data, report, or presentation included. The document is short (2497 characters) and serves as a formal regulatory communication about the withdrawal of a filing. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2008-03-27 English
S-1/A
Regulatory Filings Classification · 100% confidence The document is an Amendment No. 5 to Form S-1 Registration Statement filed with the SEC, dated October 3, 2007, for MonoSol Rx, Inc. It is a registration statement under the Securities Act of 1933, related to an initial public offering (IPO) of common stock. The text includes detailed prospectus information such as risk factors, business overview, use of proceeds, capitalization, dilution, financial data, management discussion and analysis, and other typical IPO registration statement content. This is not a financial report like an annual or quarterly report, nor is it an earnings release or a management discussion standalone. It is a regulatory filing specifically for securities registration and offering. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is substantial (15,000 characters), and it is not merely an announcement of a report but the actual registration statement filing.
2007-10-03 English
S-1/A
Regulatory Filings Classification · 95% confidence The document is an Amendment No. 4 to Form S-1 Registration Statement filed with the SEC, dated September 26, 2007, for MonoSol Rx, Inc. It is a registration statement under the Securities Act of 1933, related to an initial public offering (IPO) of common stock. The text includes details about the offering, underwriting, risk factors, business overview, and financial data. This type of filing is a registration statement for securities offering, which is not explicitly listed in the provided categories. However, the closest and most appropriate category for this type of document is Regulatory Filings (RNS), as it covers general regulatory announcements and filings that do not fit other specific categories. The document is not an Annual Report, Earnings Release, or any other specific report type but a registration statement amendment for a securities offering.
2007-09-26 English
S-1/A
Regulatory Filings Classification · 100% confidence The document is an Amendment No. 3 to Form S-1 Registration Statement filed with the SEC by MonoSol Rx, Inc. It is a registration statement under the Securities Act of 1933, used for initial public offerings (IPOs) or other securities offerings. The text includes details about the offering, the number of shares, pricing, underwriting, risk factors, business overview, and other typical prospectus content. It is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration for an IPO. Therefore, it fits the category of a Regulatory Filing (RNS) as it is a registration statement and prospectus filing with the SEC, not a report or announcement of financial results or corporate governance changes.
2007-08-29 English
S-1/A
Capital/Financing Update Classification · 100% confidence The document is an Amendment No. 2 to Form S-1 Registration Statement filed with the SEC by MonoSol Rx, Inc. It is a registration statement under the Securities Act of 1933, used for initial public offerings (IPOs) or other securities offerings. The text includes details about the offering, underwriting, risk factors, business overview, and financial data typical of a registration statement prospectus. It is not an annual report, earnings release, or any other financial report but a capital markets filing related to the company's securities offering. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial and contains detailed offering information, not just an announcement or notice, so it is not RPA or RNS.
2007-07-25 English
S-1/A
Capital/Financing Update Classification · 100% confidence The document is an Amendment No. 1 to Form S-1 Registration Statement filed with the SEC, dated June 26, 2007, for MonoSol Rx, Inc. It is a registration statement under the Securities Act of 1933, used for initial public offerings or other securities offerings. The text includes details about the offering, underwriting, risk factors, business overview, and financial data. This is clearly a capital raising filing related to the company's initial public offering. The document is not an annual report, earnings release, or any other type of report but a registration statement for securities issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2007-06-26 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.